• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

CE Mark awarded for dual-optic lens

Article

Irvine, CA-Visiogen Inc.'s dual-optic accommodating IOL (Synchrony) has received CE Mark designation.

Irvine, CA-Visiogen Inc.'s dual-optic accommodating IOL (Synchrony) has received CE Mark designation.

"Having a CE Mark allows us to expand into post-marketing research studies within Europe to further build the scientific foundation for Synchrony," said Visiogen's President and CEO Reza Zadno, PhD. "As a result of this milestone, our product has moved beyond the early investigational stages and has been validated as a commercially viable product by an international regulatory body."

The lens is the first dual-optic accommodating lens for both cataract and refractive surgery, the company said in a prepared statement. The lens is designed to provide accommodation in patients undergoing cataract surgery who may or may not have a presbyopic condition. The dual-optic design of the lens can provide vision at all distances, without the optical limitations from multifocality, according to the company.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
What keeps you up at night in ophthalmology: Part II
Chris Adams, Diopter Corp CEO
Ramin Valian, of Allergan, discusses pharmaceuticals in the glaucoma industry at Glaucoma 360
© 2024 MJH Life Sciences

All rights reserved.